πŸ‡ΊπŸ‡Έ FDA
Patent

US 8969386

Modulators of CFTR

granted A61KA61K31/444A61P

Quick answer

US patent 8969386 (Modulators of CFTR) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/444, A61P, A61P11/00, A61P11/08